Home Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4
Article Open Access

Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4

  • Shuai Yang , Jin-Ling Dong and Jin-Ming Chen ORCID logo EMAIL logo
Published/Copyright: October 22, 2021

Abstract

C15H14N2O, triclinic, P 1 (no. 2), a = 6.983(5) Å, b = 8.472(6) Å, c = 12.113(7) Å, β = 73.45°, V = 679.29(8) Å3, Z = 1, R gt (F) = 0.0566, wR ref (F 2) = 0.1875, T = 296 K.

CCDC no.: 2109607

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Red block
Size: 0.18 × 0.16 × 0.15 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.08 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 27.6°, 99%
N(hkl)measured, N(hkl)unique, R int: 4252, 3054, 0.026
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2416
N(param)refined: 175
Programs: Bruker [1], SHELX [2, 3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
O1 0.02312 (17) 0.28526 (16) 0.46273 (11) 0.0514 (4)
O2 0.29314 (16) 0.35214 (14) 0.33028 (9) 0.0426 (3)
N1 0.30503 (18) 0.00094 (15) 0.64789 (10) 0.0319 (3)
C1 0.2940 (4) 0.5395 (3) 0.18096 (18) 0.0720 (7)
H1A 0.213974 0.622278 0.151057 0.108*
H1B 0.354800 0.458629 0.123087 0.108*
H1C 0.397681 0.583680 0.202300 0.108*
C2 0.1630 (3) 0.4678 (2) 0.28415 (15) 0.0496 (5)
H2A 0.093260 0.549674 0.341189 0.060*
H2B 0.063264 0.416255 0.262729 0.060*
C3 0.2016 (2) 0.26758 (18) 0.42067 (12) 0.0331 (4)
C4 0.3522 (2) 0.15220 (17) 0.46035 (12) 0.0301 (3)
C5 0.4799 (2) 0.02059 (17) 0.36868 (12) 0.0301 (3)
H5 0.445168 0.032310 0.295651 0.036*
C6 0.3727 (2) −0.10906 (17) 0.44699 (11) 0.0308 (3)
H6 0.282916 −0.155574 0.412076 0.037*
C7 0.2545 (2) 0.01883 (17) 0.53912 (11) 0.0299 (3)
H7 0.108634 0.029251 0.550152 0.036*
C8 0.4892 (2) 0.23705 (17) 0.51030 (12) 0.0324 (4)
H8 0.574127 0.293154 0.447073 0.039*
C9 0.3729 (3) 0.3600 (2) 0.60231 (15) 0.0441 (4)
H9A 0.465995 0.411599 0.628355 0.066*
H9B 0.289547 0.307984 0.666011 0.066*
H9C 0.289531 0.437944 0.570672 0.066*
C10 0.1737 (2) −0.06464 (17) 0.74303 (11) 0.0317 (3)
C11 0.2414 (3) −0.1815 (2) 0.81168 (14) 0.0447 (4)
H11 0.377096 −0.224097 0.792268 0.054*
C12 0.1075 (3) −0.2351 (2) 0.90925 (15) 0.0525 (5)
H12 0.157013 −0.312215 0.954479 0.063*
C13 −0.0947 (3) −0.1789 (2) 0.94147 (14) 0.0496 (5)
C14 −0.1624 (3) −0.0653 (3) 0.87170 (15) 0.0527 (5)
H14 −0.299115 −0.026280 0.890073 0.063*
C15 −0.0313 (2) −0.0079 (2) 0.77470 (14) 0.0438 (4)
H15 −0.081587 0.069837 0.730201 0.053*
C16 −0.2368 (4) −0.2359 (3) 1.05037 (17) 0.0748 (7)
H16A −0.372670 −0.215889 1.045017 0.112*
H16B −0.227379 −0.179727 1.115682 0.112*
H16C −0.200175 −0.348247 1.059279 0.112*

Source of material

Dissolve 1,4-diphenyl-1,4-dihydropyridine-3-carboxylic acid ethyl ester (10 mmol) in 50 mL of methanol: tetrahydrofuran = 1:1 mixed solution, and add to a 100 mL Quartz flask. Place the reaction solution in an LED photoreactor with a wavelength of 365 nm, put it in a freezer, and irradiate it under the protection of nitrogen. After reacting for one week, the product precipitates out and is filtered to obtain the title compound.

Experimental details

All hydrogen atoms were placed in the calculated positions and all the non-hydrogen atoms were refined anisotropically.

Comment

The [2+2] -photocyclization reaction is an important type of organic photocyclization reaction. Under the induction of visible light or ultraviolet light, an addition reaction occurs between the unsaturated double bonds of two molecules, turning the double bonds into single bonds. There are two unsaturated double bonds in the molecular structure of 1,4-dihydropyridine compounds. Under light induction [2+2] photocyclization reaction can occur to generate 3,9-diazatetrastarane with inversion symmetry. Some cis/trans tetrahydrocyclobutane dipyridine compounds show pharmacological activities in the field of anti-HIV and anti-tumor [4, 6], [7], [8]. The title structure is shown in the figure. The asymmetric unit is defined as one half of the title molecule. The bond lengths and angles are in the expected ranges [5, 9].


Corresponding author: Jin-Ming Chen, School of Pharmacy, North China University of Science and Technology, Caofeidian District, 063210 Tangshan, P. R. China, E-mail:

Funding source: Hebei Provincial Universities

Award Identifier / Grant number: JQN2020007

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was financially supported by Hebei Provincial Universities (JQN2020007).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. BRUKER. SAINT (version 8.23B); Bruker AXS Inc.: Madison, Wisconsin, USA, 2013.Search in Google Scholar

2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

3. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar

4. Andreas, H., Andreas, L. First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl-4-aryl-1,4-dihydropyridine H17: biotransformation and toxicity on Hep G2 cells. Arch. Pharm. 2000, 333, 32–34.10.1002/(SICI)1521-4184(200001)333:1<32::AID-ARDP32>3.0.CO;2-QSearch in Google Scholar

5. Chen, S. J., Zhu, H., Zhang, M. M. Crystal structure of 1-benzyl-3-cyano-6- phenyl-1,2-dihydropyridine. Z. Kristallogr. NCS 2019, 234, 519–520; https://doi.org/10.1515/ncrs-2018-0516.Search in Google Scholar

6. Coburger, C., Lage, H., Molnár, J., Hilgeroth, A. Impact of novel MDR modulators on human cancer cells: reversal activities and induction studies. Pharm. Res. 2009, 26, 182–188; https://doi.org/10.1007/s11095-008-9736-7.Search in Google Scholar

7. Hilgeroth, A., Billich, A. Cage dimeric N-acyl-and N-acyloxy-4-aryl-1,4-dihydropyridines as first representatives of a novel class of HIV-1 protease inhibitors. Arch. Pharm. 1999, 332, 380–384; https://doi.org/10.1002/(sici)1521-4184(199911)332:11<380::aid-ardp380>3.0.co;2-t.10.1002/chin.200007129Search in Google Scholar

8. Hilgeroth, A., Billich, A. Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors. Arch. Pharm. 1999, 332, 3–5; https://doi.org/10.1002/(sici)1521-4184(19991)332:1<3::aid-ardp3>3.0.co;2-1.10.1002/(SICI)1521-4184(19991)332:1<3::AID-ARDP3>3.0.CO;2-1Search in Google Scholar

9. Shao, H.-Q., Lu, Y.-M., Lin, Q.-W., Wang, Y.-C., Xie, Y.-S. Crystal structure of diethyl 3,9-bis(4-fluorophenyl)-6,12-diphenyl-3,9- diazapentacyclo[6.4.0.02,7.04,11]dodecane-1,5-dicarboxylate, C40H36F2N2O4. Z. Kristallogr. NCS 2021, 236, 385–386; https://doi.org/10.1515/ncrs-2020-0552.Search in Google Scholar

Received: 2021-09-14
Accepted: 2021-10-07
Published Online: 2021-10-22
Published in Print: 2021-12-20

© 2021 Shuai Yang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Redetermination of the crystal structure of 3-bromonitrobenzene at 200 K, C6H4BrNO2 – temperature effects on cell constants
  4. Crystal structure of (E)-ethyl 2-((4-oxo-4H-chromen-3-yl)methyleneaminooxy)acetate, C14H13NO5
  5. Crystal structure of (8R,10R,14R, Z)-2-((3–Fluoropyridin-4-yl) methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6, 6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-3H-cyclopenta[a] phenanthren-3-one, C36H52FNO3
  6. Crystal structure of [6,6′-((1E,1′E)-(propane-1,3- diylbis(azaneylylidene))bis(methaneylylidene)) bis(3-chlorophenol)-κ4N,N′,O,O′] copper(II), C17H14Cl2CuN2O2
  7. The crystal structure of 6-amino-2-carboxypyridin-1-ium bromide, C6H7BrN2O2
  8. Redetermination of the crystal structure of bis[N,N′-ethylenebis(acetylacetoniminato)nickel(II)] sodium perchlorate, C24H36ClN4NaNi2O8
  9. The crystal structure of 3-methyl-2,6-dinitrophenol, C7H6N2O5
  10. The crystal structure of 5-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  11. Crystal structure of trans-tetraaqua-bis{2-carboxy-4-((5-carboxypyridin-3-yl)oxy)benzoato-κ1 N}cobalt(II) dihydrate C28H28O20N2Co
  12. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-(p-tolyl)furan, C23H23BrO2
  13. The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(benzo[d][1,3]dioxol-5-ol ato-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV)-dichloromethane(1/1), C27H25N3O10Ti
  14. Crystal structure of (((1E,1′E)-1,2-phenylenebis(methaneylylidene))bis(hydrazin-1-yl-2-ylidene))bis(aminomethaniminium) dinitrate C10H16N10O6
  15. Crystal structure of catena-poly[triaqua-(μ 2-1,3-di(1H-imidazol-1-yl)propane-κ 2 N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ 1 O)nickel(II)]N,N′-dimethylformamide (1/1), C28H35N8O8Ni
  16. The crystal structure of 3,3′-[1,4-phenylenebis(methylene)]bis(1-ethenyl-1H-imidazol-3-ium) dichloride – dichloromethane – water (1/1/1), C19H24Cl4N4O1
  17. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C13H22F12N4P2
  18. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)tin(IV), C12H8Cl4Sn
  19. Synthesis and crystal structure of 4-acetylpyrene, C18H12O
  20. Crystal structure of 2,2′-(butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(4-methoxyphenol), C20H24N2O4
  21. The crystal structure of (E)-2-(((5-((triphenylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol, C27H21N3OS2Sn
  22. Crystal structure of diaqua-bis(μ2-6-phenylpyridine-2-carboxylate-κ3N,O:O)-bis(6-phenylpyridine-2-carboxylato-κ2N,O)lead(II) – N,N-dimethylformamide – water (1/2/4), C54H58N6O16Pb2
  23. Crystal structure of methyl 4-acetoxy-3-methoxybenzoate, C11H12O5
  24. Crystal structure of 2,2′-(propane-1,3-dilylbis(azaneylylidene))bis(methanylylidene)bis(4-methylphenol), C19H22N2O2
  25. Crystal structure of dichlorido-bis(4-methylphenyl-κC1)tin(IV), C14H14Cl2Sn
  26. Crystal structure of methyl (E)-3-(4-acetoxyphenyl)acrylate, C12H12O4
  27. The crystal structure of bis(benzoato-κ2 O,O′)-(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)-copper(II), C28H22CuN2O4
  28. Crystal structure of (8R,10R,14R,Z)-12-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one–water (2/1), C37H56NO4.5
  29. Crystal structure of dimethyl-bis(4-bromophenyl-κC1)tin(IV), C14H14Br2Sn
  30. The crystal structure of the cocrystal di-μ2-chlorido-octamethyl-di-μ3-oxido-bis(2,3,4,5-tetrafluorobenzoato-κ2 O,O′)tetratin(IV) ─ octamethyl-di-μ3-oxido-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O′)-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O;O′)tetratin(IV) C58H54Cl2F24O16Sn8
  31. Crystal structure of 3-iodo-N 2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-N 1-(2-methyl-4-(perfluoropropan-2-yl)phenyl)phthalamide, C23H22F7I1N2O4S1
  32. Crystal structure of 1-(2-(4-bromophenyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)-naphthalen-2-ol – dichloromethane – dimethyl sulfoxide (1/1/1), C28H18BrNO·CH2Cl2·C2H6SO
  33. Crystal structure of [meso-5,7,7,12,14,14,-hexamethyl-1,4,8,11-tetraazacyclotetradecane]nickel(II) diperchlorate – dimethylsulphoxide (1/2), C20H48Cl2N4NiO10S2
  34. Crystal structure of 1,1′-(1,3-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S:S) palladium(II), C26H18N6PdS4
  35. The crystal structure of bis(6-phenylpyridine-2-carboxylato-κ2 N,O)copper(II), C24H16N2O4Cu
  36. Crystal structure of dichlorido-bis(4-chlorophenyl-κC)-bis(triphenylarsine oxide-κO)tin(IV), C48H38As2Cl4O2Sn
  37. Crystal structure of (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane-κ 8 N 2, O 6) potassium cyclopentadienide, [K([2.2.2]crypt)]Cp, C23H41KN2O6
  38. The crystal structure of bis(2-oxidopyridin-1-ium-3-carboxylato-κ2O,O′)-(phenantroline-κ2N,N′)manganese(II) - methanol (1/3), C27H28N4O9Mn
  39. Crystal structure of 4-(dimethylamino)pyridinium dibromido-tris(4-chlorophenyl-κC)stannate(IV), C25H23Br2Cl3N2Sn
  40. Crystal structure of (3E,5E)-1-(4-cyanobenzenesulfonyl)-3,5-bis(3-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C27H20Cl2F2N2O3S
  41. Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S
  42. Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt
  43. Crystal structure of (4-methylbenzyl)(triphenyl)phosphonium chloride dihydrate, C26H28ClO2P
  44. The crystal structure of poly[μ2-chlorido-(μ2-1,2-bis(4-pyridyl)ethane-κ2N:N′silver(I)], C12H12AgClN2
  45. Crystal structure of poly[(μ4-benzene-1,2,4,5-tetracarboxylato)-bis(μ2-adipohydrazide)dicadmium], C11H15N4O6Cd
  46. The crystal structure of (E)-N′-(butan-2-ylidene)isonicotinohydrazide 0.5 hydrate C10H13N3O·0.5H2O
  47. The crystal structure of bis(6-phenylpyridine-2-carboxylate-κ2 N,O)-(2,2′-bipyridine-κ2 N,N′)zinc(II) monohydrate, C34H26N4O5Zn
  48. The crystal structure of (1R *,2S *)-1,2-bis(2-fluorophenyl)-3,8-dimethoxyacenaphthene-1,2-diol, C26H20F2O4
  49. Crystal structure of catena-poly[(μ2-1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzotriazole-κ2N:N′)-(nitrato-κ2O,O′)silver (I)], C13H15Ag1N6O3
  50. The crystal structure of [(phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)cobalt(II)]monohydrate, C36H26N4O5Co
  51. Crystal structure of (1E)-N-[(1E)-1-(4-chlorophenyl)ethylidene]-2-[1-(4-chlorophenyl)ethylidene]hydrazine-1-carbohydrazonamide, C 17 H 17 Cl 2 N 5
  52. The crystal structure of (E)-2-((tert-butylimino)methyl)-4-chlorophenol, C11H14ClNO
  53. Crystal structure of all-cis-2,4,6-trihydroxycyclohexane- 1,3,5-triaminium chloride sulfate, C6H18ClN3O7S
  54. Crystal structure of dichlorido-bis(dimethyl sulfoxide-κO)bis(4-methylphenyl-κC 1)tin(IV), C18H26Cl2O2S2Sn
  55. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)(2,2′-bipyridyl-κ 2 N,N′)tin(IV), C22H16Cl4N2Sn
  56. Redetermination of the crystal structure of (E)-5-bromo-2-hydroxybenzaldehyde oxime, C 7 H 6 BrNO 2
  57. The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2
  58. Crystal structure of 2-chloro-3-(isopentylamino)naphthalene-1,4-dione, C 15 H 16 ClNO 2
  59. The crystal structure of bis(2-acetyl-5-methoxyphenyl)carbonate 1.5 hydrate, C19H18O7
  60. The crystal structure of poly[(μ 4-4,4′-(azanediylbis(methylene))dibenzoato-κ 4 O:N:O′:Oʺ)zinc(II)], C16H13NO4Zn
  61. The crystal structure of catena-poly[(1,10-phenanthroline-k2N,N′)-(μ3-tetraoxidomoybdato(VI)-k3O:O′:O″)manganese(II)] C12H8N2O4MoMn
  62. Crystal structure of catena-poly[(4-hydroxyl-5-(methoylcarbonyl)thiophene-2-carboxylato-κ1 O)-(μ2-piperazine-1,4-diylbis(pyridin-4-ylmethanone)-κ2 N:N′)silver(I)] monohydrate, C23H23AgN4O8S
  63. Crystal structure of bis(4-bromo-2-(((3-bromopropyl)imino)methyl)phenolato-κ2N,O)-oxido-vanadium(IV), C20H20Br4N2O3V
  64. The crystal structure of (2a′S,2a1′S,3R,5a′S,7′R)-5-(furan-3-yl)-2a′,2a1′-dihydroxy-7′-methyldecahydro-2H-spiro[furan-3,6′-naphtho[1,8-bc]furan]-2,2′(2a′H)-dione, C19H22O7
  65. The crystal structure of 3-bromopicolinic acid, C6H4BrNO2
  66. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S,S) platinum(II), C26H18N6PtS4
  67. Synthesis and crystal structure of 5-(8-((3-carboxyazetidin-1-ium-1-yl)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxybenzenesulfonate monohydrate, C20H19NO10S
  68. The crystal structure of 3-amino-5-carboxypyridin-1-ium bromide, C6H7BrN2O2
  69. The crystal structure of (2-hydroxy-5-methyl-phenyl)-(1H-pyrazol-4-yl)-methanone hemihydrate, C11H10.5N2O2.5
  70. Crystal structure of tetraaqua-(2-(4-formylphenoxy)acetato-k1O)cadmium(II), C18H22O12Cd
  71. Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4
  72. Crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl)ethylidene)-4-hydroxy – tetrahydrofuran (2/1), C17H16ClFN2O2.5
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0358/html?lang=en
Scroll to top button